fbpx An update on Mmr | Page 220 | Science in the net

An update on Mmr

Primary tabs

Read time: 1 min

Measles, mumps and rubella outbreaks still represent an healthcare issue, even though major advancements have been done towards their eradication. A poor inclination towards Mmr (measles-mumps-rubella) vaccination may constitute a major cause of increased risk to contract one of these diseases amongst specific population groups like migrants, alternative medicine users, some religious groups, healthcare professionals.
Information on Mmr vaccines coverage amongst these and others “hard-to-reach” groups was included in a document made and published Ecdc in range of the European project Venice II (Vaccine European New Integrated Collaboration Effort II). Main aim of the document was to provide a complete review of measles, mumps and rubella focuses which have been reported in the last twenty years in Europe.

Autori: 
Sezioni: 
Indice: 
Vaccination

prossimo articolo

Public-private investments in research in Horizon 2020

The European Union, through Horizon 2020, will invest more than € 28 billion in innovative research to contrast the economic stagnation. This investment will be divided into four general bunch of programs, namely the contractual Public Private Partnerships (cPPPs), the Joint Technology Initiatives (JTI), the Public-Public Initiatives and the SESAR - Joint Undertaking program. Each of these programs are different, both in